J. Witjes

发表

In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.

V. Fuster, Z. Fayad, Jason S. Lewis, 2016, JACC. Cardiovascular imaging.

Multimodal Positron Emission Tomography Imaging to Quantify Uptake of 89Zr-Labeled Liposomes in the Atherosclerotic Vessel Wall.

Z. Fayad, Jason S. Lewis, P. Robson, 2019, Bioconjugate chemistry.

Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans[S]

J. Kastelein, M. Nieuwdorp, J. Esko, 2015, Journal of Lipid Research.

Self-supervised neural network improves tri-exponential intravoxel incoherent motion model fitting compared to least-squares fitting in non-alcoholic fatty liver disease

A. Nederveen, U. Beuers, O. Gurney-Champion, 2022, Frontiers in Physiology.

Effect of Fecal Microbiota Transplantation Combined With Mediterranean Diet on Insulin Sensitivity in Subjects With Metabolic Syndrome

M. Nieuwdorp, L. Dragsted, B. Hartmann, 2021, Frontiers in Microbiology.

Duodenal Anaerobutyricum soehngenii infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over study

F. Bäckhed, J. Holst, S. Hazen, 2021, Gut.

Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis

E. Zoetendal, W. D. de Vos, M. Nieuwdorp, 2020, Hepatology communications.

Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders

K. Clément, M. Nieuwdorp, J. Verheij, 2020, Nature Reviews Gastroenterology & Hepatology.

NADP+ -dependent IDH1 R132 mutation and its relevance for glioma patient survival.

C. Van Noorden, M. D. den Brok, N. Atai, 2013, Medical hypotheses.

About the gut microbiome as a pharmacological target in atherosclerosis.

M. Nieuwdorp, D. V. van Raalte, J. Witjes, 2015, European journal of pharmacology.

Intestinal Ralstonia pickettii augments glucose intolerance in obesity

G. Bergström, F. Bäckhed, W. D. de Vos, 2017, PloS one.

Carriers of Loss-of-Function Mutations in EXT Display Impaired Pancreatic Beta-Cell Reserve Due to Smaller Pancreas Volume

M. Nieuwdorp, J. Esko, A. Nederveen, 2013, PloS one.

Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD‐NASH Cohort

A. Zwinderman, R. Sinkus, M. Nieuwdorp, 2021, Journal of magnetic resonance imaging : JMRI.

Faecal Microbiota transplantation affects liver DNA methylation in Non-alcoholic fatty liver disease: a multi-omics approach

E. Levin, P. Henneman, Daniela Stols-Gonçalves, 2023, Gut microbes.

Self-supervised neural network improves tri-exponential intravoxel incoherent motion model fitting in non-alcoholic fatty liver disease.

A. Nederveen, U. Beuers, O. Gurney-Champion, 2022, medRxiv.

Validation of the enhanced liver fibrosis (ELF)-test in heparinized and EDTA plasma for use in reflex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD)

M. Tushuizen, A. Holleboom, Anne-Marieke van Dijk, 2024, Clinical Chemistry and Laboratory Medicine.

Validation of the enhanced liver ﬁ brosis (ELF)-test in heparinized and EDTA plasma for use in re ﬂ ex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD)

M. Tushuizen, A. Holleboom, J. Witjes, 2022 .